| Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells G Okumura, A Iguchi-Manaka, R Murata, Y Yamashita-Kanemaru, ... Journal of Experimental Medicine 217 (4), e20191290, 2020 | 78 | 2020 |
| DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions K Sato, Y Yamashita-Kanemaru, F Abe, R Murata, Y Nakamura-Shinya, ... Proceedings of the National Academy of Sciences 118 (21), e2021309118, 2021 | 30 | 2021 |
| DNAM-1 promotes inflammation-driven tumor development via enhancing IFN-γ production Y Nakamura-Shinya, A Iguchi-Manaka, R Murata, K Sato, AV Vo, ... International Immunology 34 (3), 149-157, 2022 | 2 | 2022 |
| G307S DNAM-1 mutation exacerbates autoimmune encephalomyelitis via enhancing CD4+ T cell activation R Murata, S Kinoshita, K Matsuda, A Kawaguchi, A Shibuya, K Shibuya The Journal of Immunology 209 (12), 2304-2312, 2022 | 1 | 2022 |
